The Prevalence of Diabetic Peripheral Neuropathy and Related Factors

Background: Diabetic peripheral neuropathy (DPN) accounts for 80% of diabetic foot ulceration; therefore neurologic examination plays a critical role in screening at risk patients. Our objective was assessment the prevalence of DPN and related factors based on clinical findings.Methods: This cross-s...

Full description

Bibliographic Details
Main Authors: O Tabatabaei-Malazy, MR Mohajeri-Tehrani, SP Madani, R Heshmat, B Larijani
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2011-09-01
Series:Iranian Journal of Public Health
Subjects:
Online Access:http://journals.tums.ac.ir/upload_files/pdf/19271.pdf
id doaj-af3ef5bd16bc439394b459ff6f543044
record_format Article
spelling doaj-af3ef5bd16bc439394b459ff6f5430442020-12-02T00:55:46ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852011-09-014035562The Prevalence of Diabetic Peripheral Neuropathy and Related Factors O Tabatabaei-MalazyMR Mohajeri-TehraniSP MadaniR HeshmatB LarijaniBackground: Diabetic peripheral neuropathy (DPN) accounts for 80% of diabetic foot ulceration; therefore neurologic examination plays a critical role in screening at risk patients. Our objective was assessment the prevalence of DPN and related factors based on clinical findings.Methods: This cross-sectional study was conducted on 124 diabetics who were randomly recruited from Diabetes Clinic of Dr. Shariati University Hospital (Tehran/Iran) in 2004. After gathering demographic data and blood sampling for fasting blood sugar (FBS), the questionnaires United Kingdom (UK), Michigan, Diabetic Neuropathy Score (DNS), and 10-g monofilament testing were administered. Analysis tests were chi-square, pearson correlation and logistic regression.Results: The patient's age ranged 17 -75 years; with 44% male. Ninety one percent suffered from type two diabetes and the mean duration of diabetes was 10 years. The mean FBS level was 181.5 mg/dl. While the prevalence of DPN based on Michigan, DNS, and monofilament testing was about 32-38%, some 54% were diagnosed by UK test. Tingling in the lower extremity was the most frequent complaint (42%). The strongest linear correlation was reported between Michi­gan and DNS (r= 0.7), and then between monofilament test and DNS (r= 0.6). The age > 50 years, length of diabetes > 10 years, and FBS >200 mg/dl were the main risk factors for DPN based on DNS.Conclusion: It seems that the combination of Michigan and monofilament test can provide an accurate screening tool for detecting DPN. In addition, tight glucose control, regular assessment of the lower extremity, and to educate diabetics is urged in elderly diabetics, longer duration of diabetes, and those with high FBS. http://journals.tums.ac.ir/upload_files/pdf/19271.pdfDiabetic NeuropathyPrevalenceRisk Factors of NeuropathyMonofilament
collection DOAJ
language English
format Article
sources DOAJ
author O Tabatabaei-Malazy
MR Mohajeri-Tehrani
SP Madani
R Heshmat
B Larijani
spellingShingle O Tabatabaei-Malazy
MR Mohajeri-Tehrani
SP Madani
R Heshmat
B Larijani
The Prevalence of Diabetic Peripheral Neuropathy and Related Factors
Iranian Journal of Public Health
Diabetic Neuropathy
Prevalence
Risk Factors of Neuropathy
Monofilament
author_facet O Tabatabaei-Malazy
MR Mohajeri-Tehrani
SP Madani
R Heshmat
B Larijani
author_sort O Tabatabaei-Malazy
title The Prevalence of Diabetic Peripheral Neuropathy and Related Factors
title_short The Prevalence of Diabetic Peripheral Neuropathy and Related Factors
title_full The Prevalence of Diabetic Peripheral Neuropathy and Related Factors
title_fullStr The Prevalence of Diabetic Peripheral Neuropathy and Related Factors
title_full_unstemmed The Prevalence of Diabetic Peripheral Neuropathy and Related Factors
title_sort prevalence of diabetic peripheral neuropathy and related factors
publisher Tehran University of Medical Sciences
series Iranian Journal of Public Health
issn 2251-6085
publishDate 2011-09-01
description Background: Diabetic peripheral neuropathy (DPN) accounts for 80% of diabetic foot ulceration; therefore neurologic examination plays a critical role in screening at risk patients. Our objective was assessment the prevalence of DPN and related factors based on clinical findings.Methods: This cross-sectional study was conducted on 124 diabetics who were randomly recruited from Diabetes Clinic of Dr. Shariati University Hospital (Tehran/Iran) in 2004. After gathering demographic data and blood sampling for fasting blood sugar (FBS), the questionnaires United Kingdom (UK), Michigan, Diabetic Neuropathy Score (DNS), and 10-g monofilament testing were administered. Analysis tests were chi-square, pearson correlation and logistic regression.Results: The patient's age ranged 17 -75 years; with 44% male. Ninety one percent suffered from type two diabetes and the mean duration of diabetes was 10 years. The mean FBS level was 181.5 mg/dl. While the prevalence of DPN based on Michigan, DNS, and monofilament testing was about 32-38%, some 54% were diagnosed by UK test. Tingling in the lower extremity was the most frequent complaint (42%). The strongest linear correlation was reported between Michi­gan and DNS (r= 0.7), and then between monofilament test and DNS (r= 0.6). The age > 50 years, length of diabetes > 10 years, and FBS >200 mg/dl were the main risk factors for DPN based on DNS.Conclusion: It seems that the combination of Michigan and monofilament test can provide an accurate screening tool for detecting DPN. In addition, tight glucose control, regular assessment of the lower extremity, and to educate diabetics is urged in elderly diabetics, longer duration of diabetes, and those with high FBS.
topic Diabetic Neuropathy
Prevalence
Risk Factors of Neuropathy
Monofilament
url http://journals.tums.ac.ir/upload_files/pdf/19271.pdf
work_keys_str_mv AT otabatabaeimalazy theprevalenceofdiabeticperipheralneuropathyandrelatedfactors
AT mrmohajeritehrani theprevalenceofdiabeticperipheralneuropathyandrelatedfactors
AT spmadani theprevalenceofdiabeticperipheralneuropathyandrelatedfactors
AT rheshmat theprevalenceofdiabeticperipheralneuropathyandrelatedfactors
AT blarijani theprevalenceofdiabeticperipheralneuropathyandrelatedfactors
AT otabatabaeimalazy prevalenceofdiabeticperipheralneuropathyandrelatedfactors
AT mrmohajeritehrani prevalenceofdiabeticperipheralneuropathyandrelatedfactors
AT spmadani prevalenceofdiabeticperipheralneuropathyandrelatedfactors
AT rheshmat prevalenceofdiabeticperipheralneuropathyandrelatedfactors
AT blarijani prevalenceofdiabeticperipheralneuropathyandrelatedfactors
_version_ 1724410313971859456